MEDVi Review: the most format flexibility in GLP-1 telehealth — and the record to read before you buy
MEDVi does two things almost nobody else in this category does: it offers compounded semaglutide and tirzepatide as a daily tablet as well as a weekly injection, and it runs a separate low-cost membership tier that routes to branded Wegovy or Zepbound. It is also the most heavily flagged company we cover — an FDA warning letter, a BBB F grade, and a documented history of deepfaked marketing imagery. We score it on what it sells and we document the record. Read both before deciding.
- The widest set of delivery formats on this site. Semaglutide or tirzepatide, as a weekly injection or a daily under-the-tongue tablet — if needles are the dealbreaker, MEDVi and Direct Meds are the two programs here with a real alternative.
- A branded route exists — a separate membership tier lists Wegovy® and Zepbound® at $99 membership plus the medication cost. The medication itself is expensive without insurance, but the door to non-compounded product is at least on the page.
- Serious, independently verified scale: the New York Times verified $401 million in revenue, $65 million in profit and roughly 250,000 customers for 2025. (MEDVi’s own homepage advertises a customer figure about double the verified one — we use the verified number.)
- Compounded plans are all-in: physician evaluation, medication, shipping and support in one price, with no separate membership fee on the compounded tiers.
- Check before you commit — and here it is a longer list than usual: a February 2026 FDA warning letter, a BBB F with 719 complaints, a 28-day billing cycle (13 charges a year, not 12), a cancellation policy far stricter than the guarantee marketing, and a documented deepfaked-imagery investigation. All detailed below.
Pricing — what we could and could not verify
MEDVi renders its prices inside the signup flow rather than on linkable pages, so unlike Direct Meds or RemedyMeds we cannot point at a first-party price page. What its own pages do show: the branded tier listing Wegovy® pill, Wegovy® injection and Zepbound® injection at a $99 membership plus medication cost, and “no membership or hidden fees” language on the compounded plans. For the compounded dollar figures we rely on third-party pricing guides that walked MEDVi’s checkout during 2026:
| Plan (as reported by third-party pricing checks, 2026) | First month | Ongoing |
|---|---|---|
| Compounded semaglutide, weekly injection | $179 | $299 / 28 days |
| Compounded semaglutide, daily tablet | from $249 | not published |
| Compounded tirzepatide, weekly injection | from $349 | reported $399–$499 by dose |
| Compounded tirzepatide, daily tablet | from $279 | not published |
The tablet option, honestly
The daily tablets are compounded sublingual forms — dissolved under the tongue, absorbed through oral tissue — aimed squarely at people who will not inject. Two honest caveats, the same ones we give Direct Meds’ sublingual drops: published evidence for sublingual GLP-1 absorption is much thinner than for weekly injections, and third-party reviewers consistently note somewhat lower expected effect at the same nominal dose. The tablets are compounded products, which are not FDA-approved in any format. If the needle is the only thing between you and starting, this is a real option; if you are indifferent, the injection is the better-evidenced route.
The guarantee vs the cancellation policy
MEDVi’s terms page offers a weight-loss guarantee, quoted exactly: “you will be eligible for a refund of your payment (minus dr. consult fees of 25%) if you can demonstrate that you have not lost weight after following our weight loss program for a minimum of 5 months.” Its separate cancellation-and-refund policy reads very differently, in capitals: “YOU WILL NOT BE ISSUED A REFUND UPON CANCELLATION FOR THE MONTH IN WHICH THE CANCELLATION OCCURRED OR FOR ANY PRIOR MONTHS.”
What you get
- Full refund within the first 72 hours of a subscription term, if no services have been received.
- Full refund on medical disqualification.
- On multi-month plans, refunds for months where no medication was shipped.
- The 5-month guarantee above, minus the 25% consultation fee, if you can demonstrate no weight lost.
What you agree to
- No refund for the month you cancel in, or any prior month.
- Cancellation notice at least 72 hours before the next billing date.
- The same policy document states: “There is no guarantee of results or effectiveness of any treatment or care plan.”
- Thirteen 28-day billing cycles a year until you cancel.
The record — read this section even if you skip the rest
We are not aware of another company in this category with a file like this, and it is why MEDVi ranks last on our roundup despite genuinely distinctive products.
The marketing investigation. In May 2025, Futurism documented that MEDVi’s advertising used deepfaked before-and-after photos — real photos of unrelated people, years old, with new faces swapped on by AI, presented as MEDVi patients — alongside AI-generated images of branded medication boxes, a media-logo carousel implying press coverage it had not received, and a real medical professional listed as a partner who said he had no affiliation with the company and demanded removal. A follow-up in April 2026 found some AI-generated patient imagery still live. When the New York Times profiled the company in April 2026, readers pushed back hard enough that the paper appended an editor’s note acknowledging the piece should have included the regulatory and legal scrutiny the company was facing.
The regulator. The FDA sent MEDVi, LLC a warning letter (no. 721455) dated 20 February 2026, citing false or misleading claims about compounded semaglutide and tirzepatide — including labeling that implied MEDVi compounds the drugs itself and equivalence claims about brand-name products. Its pages still carry aggressive results marketing (“6x more weight loss than exercise and diet alone,” “93% kept the weight off for good”) presented without published methodology — we report those as claims, not results.
The structure. MEDVi is not itself a pharmacy or a medical practice — its terms state it does not provide healthcare services and is not acting as a pharmacy. Clinical care runs through the OpenLoop provider network and affiliated professional corporations; dispensing runs through named partner pharmacies including Triad Rx, RedRock Pharmacy and Beaker Pharmacy & Compounding. Naming its partners is more transparency than some competitors manage — but note that OpenLoop disclosed a data breach in January 2026 that is now the subject of pending class actions naming MEDVi among others. The Better Business Bureau lists MEDVi with an F rating, not accredited, 719 complaints, including 125 the company failed to respond to. ConsumerAffairs showed 3.4 out of 5 across 2,185 reviews when we last could read the page directly (4 August 2026).
See MEDVi’s current pricing →Who MEDVi is right for
Sign up if
- You will not inject, and a daily tablet is the difference between starting and not starting.
- You want a route to branded Wegovy or Zepbound through the $99 membership tier and you can afford the medication cost that sits on top.
- You want semaglutide-injection pricing near the category’s middle, all-in, with no separate membership fee on compounded plans.
- You have read the record above and are comfortable judging the product on the product.
Look elsewhere if
- Marketing integrity matters to your decision — the deepfaked-imagery record is documented, recent and unmatched in this category.
- You want responsive complaint handling — a BBB F with 125 unanswered complaints is the worst service record on this site.
- You want prices you can verify before entering the funnel — Direct Meds and RemedyMeds both publish theirs; MEDVi does not.
- You have insurance that covers GLP-1s — Found bills insurance for branded medication, which beats every cash tier here.
Frequently asked questions
How much does MEDVi cost?
MEDVi shows prices only inside its signup flow. Third-party pricing checks during 2026 report semaglutide injections at $179 first month and $299 per 28 days after, tablets from $249, and tirzepatide from $279–$349 first month with ongoing refills reported at $399–$499. The branded tier lists Wegovy and Zepbound at a $99 membership plus medication cost. Billing is every 28 days — thirteen charges a year. Confirm the figure on the checkout screen.
Is MEDVi legitimate?
It is a large, real business — the New York Times verified $401 million in revenue and roughly 250,000 customers for 2025. It is also the most heavily flagged program we cover: a February 2026 FDA warning letter, a BBB F with 719 complaints, and a documented deepfaked-marketing investigation. Both halves are on this page.
Does MEDVi offer a pill instead of injections?
Yes — compounded semaglutide and tirzepatide as a daily under-the-tongue tablet as well as a weekly injection. The sublingual route has thinner published evidence than injections, and the tablets are compounded products, which are not FDA-approved.
How does the weight-loss guarantee work?
The terms offer a refund minus a 25% consultation fee if you can demonstrate no weight lost after following the program for at least 5 months. The separate cancellation policy is stricter: no refund for the cancellation month or prior months, full refunds only in the first 72 hours before services are received or on medical disqualification — and it states there is no guarantee of results.
Can I cancel MEDVi?
Yes, with notice at least 72 hours before the next billing date. No refund for the month you cancel in or prior months; on multi-month plans, only unshipped months are refundable.
Who provides MEDVi’s medical care?
Not MEDVi itself — its terms state it does not provide healthcare services and is not acting as a pharmacy. Care runs through the OpenLoop provider network and affiliated professional corporations; dispensing through named partner pharmacies including Triad Rx, RedRock Pharmacy and Beaker Pharmacy. OpenLoop disclosed a January 2026 data breach now subject to pending class actions.
Sources
- glp1.medvi.org and home.medvi.org — branded-tier listing, compounded-plan inclusions, named pharmacy partners and on-site marketing claims.
- medvi.org terms and conditions and the MEDVi cancellation-and-refund policy — guarantee wording, refund and cancellation terms, and the statement that MEDVi does not provide healthcare services.
- Third-party pricing checks of MEDVi’s checkout during 2026 (compounded plan figures; MEDVi does not publish linkable prices).
- Better Business Bureau profile for MEDVi (Newark, DE) — F rating and complaint counts, checked 27 August 2026.
- ConsumerAffairs listing for MEDVi — 3.4 / 5 across 2,185 reviews, checked 4 August 2026 (page not directly readable on 27 August 2026).
- Futurism investigation into MEDVi’s marketing imagery (Maggie Harrison Dupré, May 2025) and follow-up reporting, April 2026.
- The New York Times profile of MEDVi (2 April 2026) and its subsequent editor’s note; NYT-verified 2025 financials.
- U.S. Food and Drug Administration warning letter to MEDVi, LLC, no. 721455, 20 February 2026.
- Public reporting on the January 2026 OpenLoop Health data breach and related pending class actions.
Figures on this page were checked on 27 August 2026 except where another date is shown. Prices, promotions and third-party ratings change frequently — always confirm the current price on the provider’s own checkout before you pay.
Go to MEDVi →